# **🌿 Health & Wellness Hub | Best Nutrition, Weight Loss & Fitness Products 💪✨**

  Novo Nordisk Shares Fall After Obesity Drug Trails Lilly Rival 🚨 Breaking News: Novo Nordisk Stock Slides After Obesity Drug Misses Rival — Can It Catch Up to Lilly? Breaking News 🚨 Shares of Novo Nordisk dropped sharply after trial data showed its next-generation obesity drug underperformed Eli Lilly ’s blockbuster treatment. Why it matters: the $100B weight-loss market is heating up — and leadership may be shifting. Click here 💻 Download Free Softwares 2026 | Best Tools for Windows & Mac – 100% Safe & Updated!** 📰 What Happened? Novo Nordisk released late-stage trial results showing its experimental obesity drug CagriSema helped patients lose about 23% of their body weight over 84 weeks . However, Eli Lilly’s competing drug Zepbound achieved roughly 25% weight loss in a comparable study — a difference analysts say could significantly impact market share. Following the data release, Novo’s shares fell as investors questioned the drug’s commercial appeal. C...

  Republican members of Congress pushed back on Thursday — albeit lightly — on the Centers for Disease Control and Prevention’s controversial  update to its webpage on vaccines and autism . On Wednesday, the CDC changed its website, walking back assurances that vaccines do not cause autism and upending decades of work by the agency to combat misinformation about vaccines and autism. Unlock the Internet: Best Free VPN Apps for PC, Android & iPhone 2025 📱💨** The changed website specifically called out Sen.  Bill Cassidy  (R-La.), who cast a critical vote to confirm HHS Secretary Robert F. Kennedy Jr. after clashing with him over vaccines. Cassidy responded to the change Thursday with a strong endorsement of vaccines, but in an  interview with Punchbowl News , declined to say he regrets voting to confirm Kennedy. Click here  **🎥 Watch Free HD Movies Online 2025 | Stream Without Signup 🍿** “Life is lived forward. What I have to do is do my best to reass...

Pioneering neuroscientist Nolan Williams—creator of the breakthrough SAINT brain-stimulation therapy for treatment-resistant depression—has died at 43. His legacy lives on. 🌟 #MentalHealth A neuroscientist, he employed a battery of high-tech tools in devising a fast-acting therapy that targets the area of the brain where depression originates. Nolan Williams, an innovativeneuroscientist who developed a noninvasive brain-stimulation technique that has delivered unusually fast relief to people with treatment-resistant depression, died on Oct. 8 at his home in Northern California. He was 43. 💥  “Discover This Secret Method Now!” His wife, Kristin Raj , said he died by suicide. Dr. Williams himself had struggled with depression, according to two of his colleagues. Dr. Williams was hired by the Stanford University School of Medicine’s department of psychiatry and behavioral sciences in 2014. He soon started its Brain Stimulation Lab, where he focused on finding rapid-acting appro...